TITLE

Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma

AUTHOR(S)
Vaquerizo, M.J.; Casan, P.; Castillo, J.; Perpina, M.; Sanchis, J.; Sobradillo, V.; Valencia, A.; Verea, H.; Viejo, J.L.; Villasante, C.; Gonzalez-Esteban, J.; Picado, C.
PUB. DATE
March 2003
SOURCE
Thorax;Mar2003, Vol. 58 Issue 3, p204
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Examines the efficacy of adding oral montelukast, a leukotriene receptor antagonist, to a constant dose of inhaled budesonide for patients with asthma. Methods; Results; Conclusion.
ACCESSION #
9360753

 

Related Articles

  • Montelukast and Dosage of Inhaled Steroids in Asthma. Walling, Anne D. // American Family Physician;11/15/1999, Vol. 60 Issue 8, p2374 

    Presents an abstract of the study `Randomised, Placebo-controlled Trial of Effect of a Leukotriene Receptor Antagonist, Montelukast, on Tapering Inhaled Corticosteroids in Asthmatic Patients,' by C.G. Lofdahl et al., which appeared on July 10, 1999 issue of the `British Medical Journal.'

  • Leukotriene receptor antagonists as add-on therapy for adults with asthma. Thomson, N.C.; Shepherd, M. // Thorax;Mar2003, Vol. 58 Issue 3, p190 

    Editorial. Examines the use of leukotriene receptor antagonists as add-on therapy for adults with moderate to severe asthma. Challenges in moderate and severe persistent asthma; Recommendations from asthma guidelines on the use of leukotriene receptor antagonists; Safety of the antagonists.

  • Inhaled glucocorticoids versus leukotriene receptor antagonists as single agent asthma treatment: systematic review of current evidence. Ducharme, Francine M. // BMJ: British Medical Journal (International Edition);3/22/2003, Vol. 326 Issue 7390, p621 

    Objective: To compare the safety and efficacy of anti-leukotrienes and inhaled glucocorticoids as monotherapy in people with asthma. Design: Systematic review of randomised controlled trials comparing anti-leukotrienes with inhaled glucocorticoids for 28 days or more in children and adults. Main...

  • Effects of Supportive Treatment such as Antioxidant or Leukotriene Receptor Antagonist Drugs on Inflammatory and Respiratory Parameters in Asthma Patients. Tug, T.; Godekmerdan, A.; Sari, N.; Karatas, F.; Erdem, E. S. // Clinical Pharmacology & Therapeutics;Mar2007, Vol. 81 Issue 3, p371 

    In this study, prospectively, we aimed to determine the effects of the different treatment alternatives on the oxidant system and inflammatory and clinic determinants during the stable period of 1 month following an asthmatic attack. Thirty-one patients (22 female, nine male) were randomly...

  • Asthma: Montelukast vs. Inhaled Corticosteroids. Bauchner, Howard // Archives of Disease in Childhood;Apr2006, Vol. 91 Issue 4, p371 

    The article compares the effectivity of montelukast and inhaled corticosteroids (ICS) in treating patients with mild persistent asthma. The authors noted that the results in the first study have favored ICS. Aside from it, study revealed that most parents prefer to use ICS instead of leukotriene...

  • Oral montelukast in acute asthma exacerbations: a randomised, double-blind, placebo-controlled trial. Crichton F Ramsay // Thorax;Jan2011, Vol. 66 Issue 1, p7 

    BACKGROUND: Although leukotriene receptor antagonists have an established role in the management of patients with chronic asthma, their efficacy in an acute asthma exacerbation is not fully known. METHODS: 87 adults with acute asthma requiring hospitalisation were randomly assigned to receive...

  • Independent Nurse: Journals watch - Obesity may influence response to some asthma drugs.  // GP: General Practitioner;3/3/2006, p76 

    The article reports that the U.S. researchers analysed data from previous trials involving 3,000 patients with moderate asthma, who were treated with a placebo, inhaled beclometasone or the leukotriene antagonist montelukast.

  • Churg Strauss Syndrome after Polypectomy in Asthmatic and Allergic Patients. Tafti, Saeid Fallah; Mokri, Bahareh; Mansoori, Nahal // Iranian Journal of Allergy, Asthma & Immunology;2009, Vol. 8 Issue 2, p111 

    Churg Strauss Syndrome (CSS) is a form of primary vasculitis that is characterized by severe eosinophilia and often granulomatous inflammation as well as history of asthma or allergy. Previously, the association between cysteinyl leukotrien receptor antagonists (LTRAs), corticosteroid withdrawal...

  • Churg-Strauss syndrome associated with montelukast. Mukhopadhyay, A.; Stanley, N. N. // Postgraduate Medical Journal;Jun2001, Vol. 77 Issue 908, p390 

    Churg-Strauss syndrome (CSS) has recently been reported in patients with asthma receiving leukotriene receptor antagonists (LTRA5). In this paper a case of CSS after treatment with montelukast is described. As in other LTRA treated cases, prior withdrawal of maintenance oral steroid may have...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics